• Home
  • News and Events

News and events

  • Email
  • Help

This section of the website contains the European Medicines Agency's news and press releases, information on meetings and events, public consultations and related information.

For a scrolling feed of all of the new and updated information published on the website, see the what's new page.

Latest news

This month's events

January 2017

M T W T F S S
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31
  • 2017-01-31 - 2017-01-31 : EMA

    Stakeholder focus group meeting on availability of lumpy skin disease (LSD) vaccines authorised to European Union (EU) standards

    The purpose of the meeting is to review the current scientific knowledge and regulatory environment for the development of LSD vaccines following incursion of the disease in 2015 and to identify regulatory options to facilitate the development and authorisation of vaccines in accordance with EU standards. The focus group meeting is within the scope of the Heads of Medicines Agencies Network Strategy on availability for veterinary vaccines that aims to increase their availability by ensuring efficient and effective cooperation between all stakeholders.

  • 2017-01-30 - 2017-01-31 : EMA

    Multi-stakeholder paediatric oncology strategy workshop (cancers with ALK aberrations)

    The aim of the EMA and the ACCELERATE platform's workshop is to review unmet therapeutic needs of children with certain types of cancer and opportunities for targeted paediatric development of innovative anti-cancer medicines. Cancers that are addressed include soft tissue and lymphoid and embryonal neoplasms such as inflammatory myofibroblastic tumour, rhabdomyosarcoma, anaplastic large cell lymphoma and neuroblastoma. Important biological aberrations such as of the anaplastic lymphoma kinase (ALK) occur across these diverse cancers, albeit in small numbers of patients, and represent challenges to address the therapeutic needs of affect paediatric patients. The workshop convenes stakeholders from patient organisations, academia, pharmaceutical industry and regulators.

  • 2017-01-30 - 2017-01-31 : HMPC

    Committee for Herbal Medicinal Products (HMPC): 30-31 January 2017

    The Committee on Herbal Medicinal Products (HMPC) is the committee that is responsible for preparing the Agency’s opinions on questions relating to herbal medicines.

  • 2017-01-24 - 2017-01-27 : PDCO

    Paediatric Committee (PDCO): 24-27 January 2017

    The Paediatric Committee (PDCO) is the committee that is responsible for assessing the content of paediatric investigation plans, which describe how a medicine should be studied in children, as well as waivers and deferrals.

  • 2017-01-24 - 2017-01-24 : EMA

    European Medicines Agency and Medicines for Europe annual bilateral meeting

    This meeting between European Medicines Agency (EMA) and Medicines for Europe is being organised in the context of the EMA annual bilateral meetings with Industry stakeholder organisations. The purpose of the meeting is to exchange views and promote dialogue on topics of common interest.

  • 2017-01-23 - 2017-01-26 : CHMP

    Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2017

    The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.

  • 2017-01-23 - 2017-01-25 : EMA

    EudraVigilance training on electronic reporting of ICSRs in the EEA

    This training course covers all aspects on the functionalities of the EudraVigilance system specifically EVWEB with regard to electronic reporting of ICSRs including practical examples and exercises in the EudraVigilance training environment. It includes fundamentals of electronic transmission of ICSRs and ICH M2 safety and acknowledgment message specifications as well as ICH E2B(R2) specifications on clinical safety data management in the frame of good pharmacovigilance practices and current EudraVigilance Business Rules.

  • 2017-01-18 - 2017-01-20 : CAT

    Committee for Advanced Therapies (CAT): 18-20 January 2017

    The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.

  • 2017-01-17 - 2017-01-19 : COMP

    Committee for Orphan Medicinal Products (COMP): 17-19January 2017

    The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

  • 2017-01-17 - 2017-01-19 : CVMP

    Committee for Medicinal Products for Veterinary Use (CVMP): 17-19 January 2017

    The Committee for Medicinal Products for Veterinary Use (CVMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning veterinary medicines.

  • 2017-01-11 - 2017-01-11 : EMA

    European Medicines Agency and Association of the European Self-Medication Industry (AESGP) annual bilateral meeting

    This meeting between European Medicines Agency (EMA) and the Association of the European Self-Medication Industry (AESGP) is being organised in the context of the EMA annual bilateral meetings with Industry stakeholder organisations. The purpose of the meeting is to exchange views and promote dialogue on topics of common interest.

  • 2017-01-09 - 2017-01-12 : PRAC

    Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 January 2017

    The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.